OncoHealth, an oncology-dedicated digital health company, scored strategic investments from Arsenal Capital Partners and McKesson (NYSE: MCK), the parties tell Axios exclusively.
Why it matters: The breadth of cancer treatment options continues growing, increasing complexity around clinical pathways and higher drug costs. Meanwhile, the oncology care management model remains outdated and ripe for innovation.
